6YH Stock Overview

Operates as a trading company in the pharmaceutical sector in Bulgaria and Serbia. More details

6YH fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	3/6
Financial Health	3/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (12.8x) is below the German market (16.1x)

Earnings grew by 12.2% over the past year

Risk Analysis

High level of non-cash earnings

Shares are highly illiquid

Debt is not well covered by operating cash flow

Does not have a meaningful market cap (€171M)

My Notes

Capture your thoughts, links and company narrative

Sopharma Trading AD Competitors

HAEMATO

HMSE:HAEK

€58.0m

Medios

XTRA:ILM1

€325.0m

LIMES Schlosskliniken

XTRA:LIK

€95.6m

VITA 34

XTRA:V3V

€70.8m

Price History & Performance

Summary of share price highs, lows and changes for Sopharma Trading AD
Historical stock prices
Current Share Price	лв42.08
52 Week High	лв0
52 Week Low	лв0
Beta	0.27
1 Month Change	0%
3 Month Change	1.70%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0.19%

Recent updates

Shareholder Returns

	6YH	DE Healthcare	DE Market
7D	0%	0.9%	0.5%
1Y	n/a	18.0%	7.2%

Return vs Industry: Insufficient data to determine how 6YH performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how 6YH performed against the German Market.

Price Volatility

Is 6YH's price volatile compared to industry and market?
6YH volatility
6YH Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.8%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.5%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 6YH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 6YH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	2,582	Ventsislav Marinov	www.sopharmatrading.bg

Sopharma Trading AD operates as a trading company in the pharmaceutical sector in Bulgaria and Serbia. The company offers its customers approximately 10,000 pharmaceutical products, including a portfolio of various brands, medicines, medical devices, sanitary materials, vitamins, food supplements, cosmetics, medical appliances, and equipment. It also provides logistic solutions for the import, storage, and distribution of pharmaceutical products, as well as services on the positioning of the products on the hospital and pharmacy markets.

Sopharma Trading AD Fundamentals Summary

How do Sopharma Trading AD's earnings and revenue compare to its market cap?
6YH fundamental statistics
Market cap	€87.57m
Earnings (TTM)	€6.83m
Revenue (TTM)	€704.10m

12.8x

P/E Ratio

0.1x

P/S Ratio

Is 6YH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6YH income statement (TTM)
Revenue	лв1.38b
Cost of Revenue	лв1.23b
Gross Profit	лв150.29m
Other Expenses	лв136.91m
Earnings	лв13.38m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0.39
Gross Margin	10.91%
Net Profit Margin	0.97%
Debt/Equity Ratio	210.5%

How did 6YH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/07/06 13:39
End of Day Share Price	2022/04/08 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sopharma Trading AD is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Mihail Dimitrov	First Financial Brokerage House

Sopharma Trading AD DB:6YH Stock Report